What Mr Barder Had to say!

I've just given FUM a quick peep today for the first time. There's a lot to learn, but on MED2002 could anyone tell me if there's any information at all (apart from what's in the header, which I presume is for MED2002 even though it says MED2001) that could help gauge how likely it is to reach the market? I understand that clinical development hasn't started yet, but was wondering if there was any earlier data, maybe from a small number of volunteers, providing anecdotal information. Failing this, it seems to be a bit of a shot in the dark on the belief that a drug that is known to cause vasodilation will work locally and strongly enough to help cause the desired effect. But what do I know — I only had a look today. Cheers.